LOUISVILLE, KY., March 2, 2016 -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and health care, announced that is has signed an agreement with Marshfield Clinic and facilitate easy integration of opiate prescription histories into electronic medical records (EMRs). The Appriss integration solution provides opiate prescription histories in real-time, at the point-of-care. This increased accessibility is expected to increase prescription monitoring data usage to improve patient safety and combat prescription drug abuse and diversion.
The Appriss secure integration technology provides a variety of options for health IT systems to integrate Prescription Monitoring Program (PMP) data into physician and pharmacist workflows. Physicians and pharmacists currently log into separate websites to retrieve a patient's opiate prescriptions and then cross-reference this data with a patient's health information in other systems. At Marshfield Clinic, the Appriss integration provides instant access to the patient's data within the electronic health records.
"Our Marshfield Clinic physicians have overwhelmingly embraced Appriss' mission of improving prescribing confidence," said Dr. Eric Penniman, East District 4 Medical Director for Primary Care. "Having access to prescription monitoring data directly from within the medication prescribing program has been significant for our physicians and they are universally grateful for this EMR tool."
The benefits of EHR integration and interoperability have long been recognized by Brandeis University's PDMP Center of Excellence (COE). The September 2012 Guidance of PDMP Best Practices recognizes that "integrating PDMP data retrieval with health information exchanges (HIE), electronic health records (EHR), and pharmacy dispensing systems should help reduce the time and effort needed for prescribers and their staff and for pharmacists to access a patient's prescription history." (http://www.pdmpexcellence.org/). The report further details that integration will maximize both the number of users (prescribers and dispensers) receiving the information and the utility for each of those users.
"By providing prescription monitoring data directly at the point-of-care, Marshfield has taken a major step towards improving patient safety in Wisconsin," said Ken Cassell, Vice President of Business Development at Appriss. "Real-time monitoring also saves valuable minutes for providers, helping to ensure the best standard of care for all patients."
For more information about Appriss integration technologies, please visit http://www.appriss.com/pmpgateway.html and http://www.appriss.com/narxcheck.html.
About Appriss
Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed. Partnering with public safety, healthcare, and leading private and public companies, Appriss delivers solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives. Appriss' solutions are always backed by excellent customer support with technical agents in the US that are available to help 24x7x365.
For more information, visit www.appriss.com (http://www.appriss.com).
CONTACT: Kathy Sue Bennett
Marketing Manager
Appriss, Inc.
[email protected]


Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 



